- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Therapeutic Aldesleukin from the original Proleukin® commercial drug.
Showing all 3 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price | |
|---|---|---|---|---|---|---|---|---|---|---|
IL-2RB |
Recombinant protein |
Proleukin® |
1,1 mg/mL |
– |
0,022 mg |
-80°C |
07/2021 |
738,00 € |
||
IL-2RB |
Recombinant protein |
Proleukin® |
1,1 mg/mL |
– |
0,088 mg |
-80°C |
03/2024 |
778,00 € |
||
IL-2RB |
Recombinant protein |
Proleukin® |
1,1 mg/mL |
– |
0,044 mg |
-80°C |
07/2024 |
417,00 € |
| Drug name | Proleukin® |
| INN | Aldesleukin |
| API type | Recombinant cytokine |
| Pharmacotherapeutic group | |
| ATC code | |
| Target of antibody | IL-2 R receptor |
| General function | |
| Short description | |
| Pharmacodynamic properties (Mechanism of action; Source EMA document) | |
| Pharmacodynamic properties (Pharmacodynamic effects; Source EMA document) | |
| Original license holder | |
| Marketing authorisation numbers | |
| Marketing authorisation holder | |
| Name of the manufacturer of the biological active substance | |
| Name and address of the manufacturer(s) responsible for batch release | |
| Max shelf life | 24 months |
| Storage conditions | 2°C – 8°C |
| List of excipients | |
Let us know about your inquiry details and we’ll contact you shortly.
